Sclerostin 抗体 (Middle Region)
Quick Overview for Sclerostin 抗体 (Middle Region) (ABIN358752)
抗原
See all Sclerostin (SOST) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 141-171, Middle Region
-
特异性
- This antibody recognizes SOST (Center).
-
纯化方法
- Protein A Chromatography, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
-
免疫原
- KLH conjugated synthetic peptide between 141~171 amino acids from the Center region of Human SOST.
-
亚型
- Ig Fraction
-
-
-
-
应用备注
-
ELISA: 1/1,000. Western Blot: 1/50-1/100Immunohistochemistry: 1/10-1/50.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.25 mg/mL
-
缓冲液
- PBS with 0.09 % (W/V) Sodium Azide
-
储存液
- Sodium azide
-
注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freezing and thawing.
-
储存条件
- 4 °C/-20 °C
-
储存方法
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
-
-
- Sclerostin (SOST)
-
别名
- Sclerostin / SOST
-
背景
- Sclerostin is a secreted glycoprotein with a C-terminal cysteine knot-like (CTCK) domain and sequence similarity to the DAN (differential screening-selected gene aberrative in neuroblastoma) family of bone morphogenetic protein (BMP) antagonists. Loss-of-function mutations in this gene are associated with an autosomal-recessive disorder, sclerosteosis, which causes progressive bone overgrowth. A deletion downstream of the sclerostin gene, which causes reduced sclerostin expression, is associated with a milder form of the disorder called van Buchem disease.
-
基因ID
- 50964, 9606
-
UniProt
- Q9BQB4
抗原
-